APA (7th ed.) Citation

Fei, X., Zheng, Z., Zhao, Z., Ren, D., Wang, S., Ye, S., . . . Ma, Q. Anlotinib combined with tislelizumab in the treatment of primary small cell neuroendocrine carcinoma of the prostate: A case report and literature review. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Fei, Xin, et al. Anlotinib Combined with Tislelizumab in the Treatment of Primary Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review. Frontiers Media S.A.

MLA (9th ed.) Citation

Fei, Xin, et al. Anlotinib Combined with Tislelizumab in the Treatment of Primary Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review. Frontiers Media S.A.

Warning: These citations may not always be 100% accurate.